Use of gemcitabine, a drug that can be effective in treating advanced and resected pancreatic cancer, did not result in improved overall survival after pancreatic cancer resection (surgical removal) compared to patients who received fluorouracil and folinic acid, another treatment regimen that has shown effectiveness, according to a new study.
Read »- Anonymous
Navigation
User login
Visit the BiotechMashup Blog
Best upcoming scoops - Health
- Americans find doing their own taxes simpler than improving diet and health
- Neuropeptide Y2 Receptor (NPY2R) Expression in Saliva Predicts Feeding Immaturity in the Premature Neonate
- Tinnitus Severity Is Reduced with Reduction of Depressive Mood – a Prospective Population Study in Sweden
- Deep Brain Stimulation of Nucleus Accumbens Region in Alcoholism Affects Reward Processing
- The Role of Attention in Ambiguous Reversals of Structure-From-Motion